Indication

Lymphogranuloma venereum

Lymphogranuloma venereum is a systemic sexually transmitted infection caused by invasive L1, L2, or L3 serovars of the bacterium *Chlamydia trachomatis*. Read more about Lymphogranuloma venereum

222 drugs 110 manufacturers

Advertisement

Drugs that treat it

Common Lymphogranuloma venereum therapies.

Showing 154–162 of 222 drugs

Filter & compare in the drug finder →Opens the drug finder with Lymphogranuloma venereum preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Lymphogranuloma venereum.

Lymphogranuloma venereum is a systemic sexually transmitted infection caused by invasive L1, L2, or L3 serovars of the bacterium *Chlamydia trachomatis*.

The pathogen preferentially targets regional lymphatic tissues and mucosal surfaces, classically producing a transient, painless primary genital ulcer followed by painful inguinal or femoral lymphadenopathy with suppurative bubo formation.

Particularly among men who have sex with men, it frequently manifests as severe, invasive proctocolitis marked by hemorrhagic rectal discharge, tenesmus, and constipation.

If left untreated, chronic lymphatic obstruction and persistent inflammation can result in irreversible complications, including genital elephantiasis, fistulas, and colorectal strictures.

Personalize your experience

Follow Lymphogranuloma venereum and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it